George Yancopoulos

Insider Reports History

Entity
Individual
Location
777 Old Saw Mill River Road, Tarrytown, New York
Signature
By: Richard Gluckselig as attorney-in-fact For: George D. Yancopoulos
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by George Yancopoulos:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REGENERON PHARMACEUTICALS, INC. Bd. Co-Chair, President & CSO, Director Common Stock 868,994 $882 M $1,015.02 Jun 10, 2024 Direct
REGENERON PHARMACEUTICALS, INC. Bd. Co-Chair, President & CSO, Director Common Stock 180,000 $183 M $1,015.02 Jun 10, 2024 By Trust for Chldn.
REGENERON PHARMACEUTICALS, INC. Bd. Co-Chair, President & CSO, Director Common Stock 56,048 $56.9 M $1,015.02 Jun 10, 2024 by Children
REGENERON PHARMACEUTICALS, INC. Bd. Co-Chair, President & CSO, Director Common Stock 5,903 $5.99 M $1,015.02 Jun 10, 2024 By 401(k) Plan
REGENERON PHARMACEUTICALS, INC. Bd. Co-Chair, President & CSO, Director Common Stock 0 $0 $1,015.02 Jun 10, 2024 by 2022 GRAT II
REGENERON PHARMACEUTICALS, INC. Bd. Co-Chair, President & CSO, Director 2019 Performance Stock Units 0 $844.09 Dec 11, 2023 Direct
REGENERON PHARMACEUTICALS, INC. Bd. Co-Chair, President & CSO, Director Non-Qualified Stock Option (right to buy) 0 Feb 15, 2024 Direct

Insider Reports Filed by George Yancopoulos

Symbol Company Period Transactions Value $ Form Type Date Filed Role
REGN REGENERON PHARMACEUTICALS, INC. Jun 10, 2024 2 0 4 Jun 12, 2024 Bd. Co-Chair, President & CSO, Director
REGN REGENERON PHARMACEUTICALS, INC. May 16, 2024 12 -48,636,545 4 May 17, 2024 Bd. Co-Chair, President & CSO, Director
REGN REGENERON PHARMACEUTICALS, INC. May 15, 2024 25 -48,793,727 4 May 17, 2024 Bd. Co-Chair, President & CSO, Director
REGN REGENERON PHARMACEUTICALS, INC. Apr 29, 2024 2 0 4 May 1, 2024 Bd. Co-Chair, President & CSO, Director
REGN REGENERON PHARMACEUTICALS, INC. Feb 15, 2024 3 -48,863,868 4 Feb 20, 2024 Bd. Co-Chair, President & CSO, Director
REGN REGENERON PHARMACEUTICALS, INC. Jan 2, 2024 1 -15,163,200 4 May 1, 2024 Bd. Co-Chair, President & CSO, Director
REGN REGENERON PHARMACEUTICALS, INC. Jan 2, 2024 1 -15,163,200 4 Jan 4, 2024 Bd. Co-Chair, President & CSO, Director
REGN REGENERON PHARMACEUTICALS, INC. Dec 11, 2023 3 -10,838,960 4 Dec 13, 2023 Bd. Co-Chair, President & CSO, Director
REGN REGENERON PHARMACEUTICALS, INC. Mar 23, 2023 8 -2,940,374 4 Mar 27, 2023 President and Chief Scientific, Director
REGN REGENERON PHARMACEUTICALS, INC. Feb 6, 2023 1 -10,552,255 4 Feb 8, 2023 President and Chief Scientific, Director
REGN REGENERON PHARMACEUTICALS, INC. Dec 22, 2021 6 -91,395,761 4 Dec 23, 2021 President and Chief Scientific, Director
REGN REGENERON PHARMACEUTICALS, INC. Aug 13, 2021 3 -31,264,263 4 Aug 17, 2021 President and Chief Scientific, Director
REGN REGENERON PHARMACEUTICALS, INC. Aug 5, 2021 3 -30,003,000 4 Aug 6, 2021 President and Chief Scientific, Director
REGN REGENERON PHARMACEUTICALS, INC. Jun 21, 2021 17 -43,112,141 4 Jun 23, 2021 President and Chief Scientific, Director